Company News

Company News

30 years 10

Thirty Years of Innovation, A New Chapter Ahead

BioDuro Celebrates 30th Anniversary in Shanghai with Global Frontiers in Pharmaceutical Innovation Thirty years is a long time in any industry. In pharmaceutica...

Shutterstock 1109407401 1

BioDuro Congratulates Gilva Therapeutics on Advancing GV-100 into Phase I Clinical Development in Australia

May 28, 2026 – BioDuro congratulates Gilva Therapeutics on receiving approval in Australia to initiate a Phase I clinical trial for GV-100, a novel oral selec...

Cti press release

BioDuro and CTI Biotechnology Enter Strategic Partnership to Accelerate Preclinical Drug Development

IRVINE, California, April 28, 2026 – BioDuro, a trusted global Contract Research, Development and Manufacturing Organization (CRDMO), today announced a strate...

Ecovadis banner final

Three BioDuro Sites Recognized with EcoVadis Gold and Silver Medals

BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has established a joint venture with Cenr...

0312 sab pr final

BioDuro Appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors

Irvine, Calif., - March 12, 2026 — BioDuro, a leading global contract research, development, and manufacturing organization (CRDMO), today announced the appoi...

Taiwan jv pr banner new 0227

BioDuro and Cenra Launch Joint Venture to Expand Resilient Global API Manufacturing Capacity

IRVINE, California, March 3, 2026 – BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has...

Daewoong

BioDuro Once Again Named 2025 Best CRO by Daewoong Pharmaceutical

February 2026 — BioDuro has once again been honored with the 2025 Best CRO Award by Daewoong Pharmaceutical, recognizing its excellence among within Daewoong&...

0127 li hong wan

BioDuro Appoints Hong Wan as Senior Vice President of DMPK

We're excited to welcome Dr. Hong Wan to BioDuro as Senior Vice President of DMPK. He will lead our global DMPK and bioanalytical functions, further streng...

Efdfa26fbb2bd1b3de18ecf7f34e92ffe6e321d6

BioDuro Completes Divestiture of its Drug Product Manufacturing Facility in Irvine, California

IRVINE, Calif. January 12, 2026 – BioDuro, a leading global contract research, development, and manufacturing organization (CRDMO), today announced the comple...

Peptide sbu pr li banner

BioDuro Launches Dedicated Peptide Business Unit, Accelerating Integrated Drug Discovery Solutions

IRVINE, Calif. – November 18, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the l...

New board member

Christopher Conway Joins BioDuro Board, Enhancing Strategic Leadership

IRVINE, Calif. – August 20, 2025 –BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that Chr...

Atombeat pr en0729

BioDuro and Atombeat Announce Partnership to Launch an AI-Powered Platform for Accelerated Peptide Drug Discovery

IRVINE, Calif. – July 30, 2025 – BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), and Atombeat Inc., a le...

Pr ai drug design

BioDuro Partners with Silicogenix to Accelerate Novel Drug Discovery for Complex Diseases

IRVINE, Calif. – June 10, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced a groundb...

0508 sbti web&linkedin

BioDuro Receives SBTi Validation for Greenhouse Gas Emission Targets

IRVINE, CALIF. – May 8, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its greenho...